Nucleai and Merck KGaA Darmstadt, Germany Launch Translational Medicine Collaboration Utilizing Nucleai’s AI-Powered Biomarker Platform
Nucleai (www.nucleaimd.com), a precision medicine company using AI-powered image analysis technology to support novel pathology-based biomarker development, and Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that they have entered into a long-term collaboration to leverage Nucleai's image analysis and biomarker discovery platform for several Merck KGaA, Darmstadt, Germany clinical stage oncology assets.
As part of the collaboration, Merck KGaA, Darmstadt, Germany will leverage Nucleai’s platform for exploratory research, with the potential to further develop identified pathology-based biomarkers as companion diagnostics. The collaboration will further utilize Nucleai’s technology to expand onto Merck KGaA, Darmstadt, Germany’s analysis capabilities, enabling faster turnaround time and scale for future studies.
Nucleai's platform analyzes tissue images using computer vision and machine learning methods to model the tumor and the immune system's spatial characteristics, creating unique and specific histological biomarkers that may help predict patient response. These biomarkers hold the potential to provide better understanding of cancer biology, enable further stratification of responder/non-responder patient populations, and improve the success rate of clinical trials and patient care. To develop its platform, Nucleai leverages proprietary datasets of pathology images and clinical data from leading hospitals and Health Maintenance Organizations (HMOs) in the U.S and Israel.
“We are thrilled to announce another major collaboration with a leading pharmaceutical company like Merck KGaA, Darmstadt, Germany to identify and develop novel biomarkers for their oncology assets. By combining real world and clinical trial datasets, with an integrated and scalable technology platform, we are harnessing the power of AI and big data and setting the standard for future precision medicine collaborations, adds Avi Veidman, CEO and Co-Founder of Nucleai.”
Nucleai is a precision medicine company that has developed an AI-powered image analysis platform to unlock the power of spatial biology from pathology images. Nucleai’s ATOM platform, built and trained off large-scale proprietary datasets, leverages computer vision and deep neural networks to structure and characterize tissue and cell architecture in pathology images to identify spatial characteristics that predict response to therapy and inform treatment decision. We are currently partnered with leading pharmaceutical companies to discover novel spatial biomarkers, develop pathology-based companion diagnostics assays and drive improved patient outcomes. For more information, please visit www.nucleaimd.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Jonathan Daniels – VP of Sales
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LYCRA ® FitSense ™ Technology Delivers Breakthrough Benefits in Modesty and Bra Foam Replacement27.7.2021 11:00:00 CEST | Press release
The LYCRA Company, a global leader in developing innovative solutions for the textile, apparel, and personal care industries, today introduced a breakthrough LYCRA® FitSense™ technology innovation that reduces or eliminates the need for bra foam. This patent-pending bra cup application can be used in intimate apparel such as traditional wired, non-wired or unlined bras (including bralettes and sport bras), plus activewear and swimwear. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210727005390/en/ A woman wears a bra and panty set with LYCRA® FitSense™ technology for nipple concealment and lightweight, targeted support. (Photo: Business Wire) LYCRA® FitSense™ technology is a water-based, solvent-free dispersion that is comprised of the same molecule as LYCRA® fiber. The dispersion is screen-printed directly onto the bra fabric, increasing the power of the fabric in precise areas. The power increase in the bra cup effectivel
Prokarium Appoints Kristen Albright as Chief Executive Officer27.7.2021 10:00:00 CEST | Press release
Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, today announced the appointment of Kristen Albright, PharmD, as Chief Executive Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210727005171/en/ Kristen Albright, PharmD, Chief Executive Officer of Prokarium (Photo: Business Wire) Dr. Albright is an accomplished industry leader with broad experience in finance, business development and operations. She joined Prokarium in 2018, most recently serving as Chief Operating Officer, and has led Prokarium’s expanding development efforts in oncology while also securing an investment from The Wellcome Trust to fund the company’s lead vaccine program into clinical development. She follows Ted Fjällman, PhD, who will continue to support the company as a member of the Board of Directors. “As Prokarium accelerates its drug development efforts within oncology, Kristen brings extensive f
Neustar Unveils UltraBot Protect to Deliver More Visibility Into and Control Over Web Application Traffic27.7.2021 09:37:00 CEST | Press release
Neustar Inc., a global information services and technology company and leader in identity resolution, today introduced UltraBot Protect to provide users with more visibility into, and control over, their application layer traffic. UltraBot Protect delivers enhanced capabilities that allow users to examine traffic patterns to determine risk, easily set rules, and block nefarious web application traffic, all through an intuitive, dynamic and comprehensive user interface or Neustar’s extensible API, both of which deliver actionable data and insights to better manage incoming traffic. Neustar’s portfolio of application security products, which also includes UltraDDoS Protect and UltraWAF, utilises deep insights of network traffic to ensure users’ digital networks are secure across all touchpoints. Newly augmented with the robust bot management capabilities of UltraBot Protect, it becomes even more powerful. “As digital initiatives accelerated during the pandemic, companies invested in appl
Reply Creative Challenge 2021: With an Idea Developed for easyJet, a Team of Young Students From Politecnico of Milan Wins the Competition27.7.2021 09:30:00 CEST | Press release
With the project “easyDream”, team Watermelon won the 2021 edition of the Creative Challenge, the largest team-based competition in Europe for students and young creatives and part of the Reply Challenges program. Launched last May 21st with the online qualification marathon (running 48h), the challenge gathered over 12,000 creative talents (+94% vs. 2020 edition) from 82 countries around the World to focus their creative efforts on nine categories: "Brand Activation", "Brand Experience", "Employer Branding", "Employee Engagement", "Digital Customer Experience", "Digital Gamification", "Fan-base activation", "Innovation Design" and "Social Media". Spread across over 1,900 teams (+90% vs. 2020 edition), the young talents - with an average age between 14 and 24 - put their skills and personalities into the development of a creative concept based on a real brief created by Reply in collaboration with the Brand Partners of the initiative: AC Milan, Ducati, easyJet, Miele, Mondelez Internat
Arqit and Dentons Launch Secure Identity Product27.7.2021 09:27:00 CEST | Press release
Arqit Limited (“Arqit”), a leader in quantum encryption technology, today announces that it has signed a contract with leading law firm Dentons (London) to co-develop a quantum safe, self-sovereign identity system (“SSI”), which allows users to control their own identities and selectively grant access permissions to firms. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210727005467/en/ The new product is called QuantumKeep™. It transforms on boarding and compliance checking from a repetitive, burdensome, and time-consuming process that involves transmitting identity documents over insecure channels, into a hassle-free and secure exchange under the client's control. It allows an initial data capture by one firm that has been granted permission by the user, to be securely stored and represented anonymously to other parties in future – building a chain of growing trust in the quality of the identity. Data is stored in the form
SWIFT Launches SWIFT Go, a Fast, Cost-Effective Service for Low-Value Cross-Border Payments27.7.2021 09:16:00 CEST | Press release
SWIFT today announces the launch of SWIFT Go, a transformative new service that enables small businesses and consumers to send fast, predictable, highly secure, and competitively priced low-value cross-border payments anywhere in the world, direct from their bank accounts. Seven global banks, which collectively handle 33 million low-value cross-border payments per year, are already live with the service. SWIFT Go enables financial institutions to offer a seamless payments experience for low value transactions often initiated by small- and medium-sized enterprises (SMEs) to pay suppliers overseas and by consumers sending money to friends and family internationally. Using tighter service level agreements between institutions and pre-validation of data, SWIFT Go enables banks to provide their end customers a fast and predictable payments experience with upfront visibility on processing times and costs. The SWIFT Go service builds on the high-speed rails of SWIFT gpi, which have transforme
FINBOURNE Integrates with FlexNOW Delivering Deep Integration Without Complex Implementation27.7.2021 09:00:00 CEST | Press release
FlexTrade Systems (@FlexTrade), a global leader in multi-asset execution and order management systems, and FINBOURNE, the award winning financial technology firm, announce a collaboration to integrate FlexNOW – FlexTrade’s one-click install EMS – with FINBOURNE’s LUSID which is a cloud native, API first Portfolio Management System (PMS) and Investment Data Management System (IDMS). Servicing the entirety of the buy side, clients using LUSID with the FlexNOW integration will have the front to back power and flexibility to execute and manage complex multi asset strategies on a global scale. The integration will empower clients with best execution even in the most challenging markets while ensuring they can manage their positions and risk on a real time basis. Thomas Mchugh, co-founder and CEO of FINBOURNE said: “FINBOURNE is changing the way the industry manages and interacts with its data, democratising the investment management processes and reducing complexity. A combination of client
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom